in vitro , healthy donor peripheral blood mononuclear cells , purified B cells , monocytes , natural killer ( NK ) cells , or combinations thereof were incubated with rituximab , rituximab-F ( ab ' ) 2 , or medium and MIP-1 , IL-10 , interferon - , and tumor necrosis factor - levels were measured in the supernatant .